Reutlingen-Ohmenhausen, Germany

Meike Moschallski

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Meike Moschallski: Innovator in Microfluidic Technology

Introduction

Meike Moschallski is a notable inventor based in Reutlingen-Ohmenhausen, Germany. He has made significant contributions to the field of microfluidics, particularly in the separation and manipulation of bioparticles. His innovative work has led to the development of a unique microfluidic cell that enhances the efficiency of bioparticle processing.

Latest Patents

Meike Moschallski holds one patent for a microfluidic cell designed for the dielectrophoretic separation, accumulation, and/or lysis of polarizable bioparticles. This patent describes a microfluidic cell that features an interdigital electrode system composed of two electrode groups with interdigitated electrodes. Additionally, it includes a micromixer with microchannels and microelevations. The design places both the interdigital electrode system and the micromixer on the same side of the cell, which improves the separation, accumulation, and lysis characteristics of the bioparticles. The patent also outlines a microfluidic system that incorporates this cell and details methods for utilizing it effectively.

Career Highlights

Meike Moschallski is currently employed at Robert Bosch GmbH, where he continues to innovate in the field of microfluidics. His work at Bosch allows him to collaborate with leading experts and contribute to cutting-edge research and development projects.

Collaborations

Some of Meike's coworkers include Michael Stumber and Martina Daub, who are also involved in advancing technologies related to microfluidics and bioparticle manipulation.

Conclusion

Meike Moschallski's contributions to microfluidic technology exemplify the impact of innovative thinking in scientific research. His patent for a microfluidic cell represents a significant advancement in the field, showcasing his dedication to improving bioparticle processing methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…